Immunization with lytic polysaccharide monooxygenase CbpD induces protective immunity against Pseudomonas aeruginosa pneumonia.
Fatemeh AskarianChih-Ming TsaiGabriele CordaraRaymond H ZurichElisabet BjanesOle GoltenHenrik Vinther SørensenArmin KoushaAngela MeierElvis Mashingaidze ChikwatiJack Ansgar BruunJudith Anita LudviksenBiswa ChoudhuryDesmond TrieuStanley DavisPer Kristian Thorén EdvardsenTom Eirik MollnesGeorge Y LiuUte KrengelDouglas J ConradGustav Vaaje-KolstadVictor NizetPublished in: Proceedings of the National Academy of Sciences of the United States of America (2023)
Pseudomonas aeruginosa (PA) CbpD belongs to the lytic polysaccharide monooxygenases (LPMOs), a family of enzymes that cleave chitin or related polysaccharides. Here, we demonstrate a virulence role of CbpD in PA pneumonia linked to impairment of host complement function and opsonophagocytic clearance. Following intratracheal challenge, a PA ΔCbpD mutant was more easily cleared and produced less mortality than the wild-type parent strain. The x-ray crystal structure of the CbpD LPMO domain was solved to subatomic resolution (0.75Å) and its two additional domains modeled by small-angle X-ray scattering and Alphafold2 machine-learning algorithms, allowing structure-based immune epitope mapping. Immunization of naive mice with recombinant CbpD generated high IgG antibody titers that promoted human neutrophil opsonophagocytic killing, neutralized enzymatic activity, and protected against lethal PA pneumonia and sepsis. IgG antibodies generated against full-length CbpD or its noncatalytic M2+CBM73 domains were opsonic and protective, even in previously PA-exposed mice, while antibodies targeting the AA10 domain were not. Preexisting antibodies in PA-colonized cystic fibrosis patients primarily target the CbpD AA10 catalytic domain. Further exploration of LPMO family proteins, present across many clinically important and antibiotic-resistant human pathogens, may yield novel and effective vaccine antigens.
Keyphrases
- pseudomonas aeruginosa
- wild type
- cystic fibrosis
- machine learning
- high resolution
- endothelial cells
- biofilm formation
- end stage renal disease
- newly diagnosed
- escherichia coli
- chronic kidney disease
- acinetobacter baumannii
- ejection fraction
- pluripotent stem cells
- type diabetes
- antimicrobial resistance
- cardiovascular disease
- acute kidney injury
- immune response
- dendritic cells
- deep learning
- adipose tissue
- artificial intelligence
- community acquired pneumonia
- drug delivery
- mass spectrometry
- dual energy
- prognostic factors
- water soluble
- big data
- risk factors